+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Resynchronization Therapy (CRT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5229223
  • Report
  • December 2020
  • Region: Global
  • 146 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • LivaNova Plc
  • Medico S.p.A.
  • Medtronic Plc
  • MORE
The global cardiac resynchronization therapy (CRT) market grew at a CAGR of around 7% during 2014-2019. Cardiac resynchronization therapy (CRT), or biventricular pacing, refers to a therapeutic procedure to correct or facilitate synchronized beating of the right and left ventricle of the heart. This therapy aids in improving the functioning of the heart, increasing the blood flow and facilitating faster recovery of the patient. It involves the use of a defibrillator to generate a pulse and thin insulated wires or leads to send electric impulses into the lower chambers of the heart. The device is surgically implanted and is connected to an external computer for periodic monitoring of the heart. It sends small electrical impulses to the left and right ventricles to support contraction at the same time.

The increasing prevalence of cardiovascular diseases (CVDs) across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to ailments such as arrhythmias, congenital heart disease and atrial fibrillation, is providing a thrust to the market growth. In line with this, increasing health consciousness and awareness regarding the available treatment alternatives for heart-related ailments is also contributing to the market growth. Various technological advancements, such as the development of MRI-safe and wireless CRT devices, are acting as other growth-inducing factors. These novel systems aid in optimizing CRT programming and multipoint pacing to promote the healthy activity of the heart. Other factors, including increasing healthcare expenditures capacities of the individuals, along with improvements in the healthcare infrastructure, especially in the developing nations, are anticipated to drive the market further. Looking forward, the publisher expects the global cardiac resynchronization therapy (CRT) market to continue its moderate growth during the next five years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global cardiac resynchronization therapy (crt) market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, type, application and end user.

Breakup by Type:
  • CRT-Defibrillator
  • CRT-Pacemaker
Breakup by Application:
  • Intraventricular Dyssynchrony
  • Interventricular (V-V) Dyssynchrony
  • Atrioventricular (A-V) Dyssynchrony
Breakup by End User:
  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgery Centers
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Inc. and MicroPort Scientific Corporation.

Key Questions Answered in This Report:
  • How has the global cardiac resynchronization therapy (CRT) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cardiac resynchronization therapy (CRT) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cardiac resynchronization therapy (CRT) market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • LivaNova Plc
  • Medico S.p.A.
  • Medtronic Plc
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cardiac Resynchronization Therapy (CRT) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 CRT-Defibrillator
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 CRT-Pacemaker
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Application
7.1 Intraventricular Dyssynchrony
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Interventricular (V-V) Dyssynchrony
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Atrioventricular (A-V) Dyssynchrony
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgery Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Biotronik SE & Co. KG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 LivaNova Plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Medico S.p.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Medtronic Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merit Medical Systems Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 MicroPort Scientific Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio

List of Figures
Figure 1: Global: Cardiac Resynchronization Therapy Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2019
Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2019
Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2019
Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2019
Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: Cardiac Resynchronization Therapy (CRT)in: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: Cardiac Resynchronization Therapy (CRT)in: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter’s Five Forces Analysis

List of Tables
Table 1: Global: Cardiac Resynchronization Therapy Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Type (in Million US$), 2020-2025
Table 3: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 4: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by End User (in Million US$), 2020-2025
Table 5: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Cardiac Resynchronization Therapy Market Structure
Table 7: Global: Cardiac Resynchronization Therapy Market: Key Players
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • LivaNova Plc
  • Medico S.p.A.
  • Medtronic Plc
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corporation
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll